CBD-Cancer Research

Cannabinoids: Do they have a role in cancer therapy?
Liu & Powles, 2006
Cannabidiol—recent advances.
Mechoulam et al., 2007
Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids
Liu et al., 2010
Effects of Endocannabinoid System Modulation on Cognitive and Emotional Behavior
Zanetti et al., 2011
Cannabidiol as potential anticancer drug
Massi et al., 2013
The Endocannabinoid System and its Modulation by Phytocannabinoids
Marzo and Piscitelli, 2015
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Ladin et al., 2016
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
Scott et al., 2017
The current state and future perspectives of cannabinoids in cancer biology
Śledziński et al., 2018
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner
Jordà et al., 2004
Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway
Powles et al., 2005
CBD-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression
McKallip et al., 2006
Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids
Liu et al., 2010
Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules
Scott et al., 2013
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
Yeshurun et al., 2015
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
Scott et al., 2017
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism
Fogli et al., 2006
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
Carracedo et al., 2006
Cannabinoids in pancreatic cancer: Correlation with survival and pain
Michalski et al., 2008
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
Donadelli et al., 2011
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
Dando et al., 2013
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids
Yasmin-Karim, et al., 2018
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
Ferro et al., 2018
Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response
McKallip et al., 2005
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Ligresti et al., 2006
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
McAllister et al., 2007
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
Shrivastava A et al., 2011
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
McAllister et al., 2011
Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules
Scott et al., 2013
Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
Murase et al., 2014
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer
Elbaz et al., 2015
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration
Scott et al., 2017
Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol
Kenyon, Liu, & Dalgleish, 2018
Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival
Marcu et al., 2010
A combined preclinical therapy of cannabinoids and temozolomide against glioma
Torres, 2011
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
Soroceanu et al., 2013
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
Solinas et al., 2013
Cannabinoid signaling in glioma cells
Ellert-Miklaszewska et al., 2013
The combination of cannabidiol and Δ9-tetrahydrocannabinolenhances the anticancer effects of radiation in an orthotopicmurine glioma model
Scott, Dalgleish, & Liu, 2014
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
Nabissi et al., 2015
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma
GW Pharmaceuticals, 2017
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Dumitru et al., 2018